5-methyl-pyrazine-2-carboxylic acid diethylamide | 39102-12-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 5-methyl-pyrazine-2-carboxylic acid diethylamide
• 英文别名: N,N-diethyl-5-methylpyrazine-2-carboxamide
• CAS: 39102-12-0
• 化学式: C₁₀H₁₅N₃O
• mdl: MFCD10654206
• 分子量: 193.249
• InChiKey: ZEGBVDPNLVGPAG-UHFFFAOYSA-N

物化性质

• 沸点：
  337.4±42.0 °C(Predicted)
• 密度：
  1.070±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  46.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-methyl-pyrazine-2-carboxylic acid diethylamide 在 双氧水 、 溶剂黄146 作用下， 反应 6.0h， 生成 5-methyl-4-oxy-pyrazine-2-carboxylic acid diethylamide
  参考文献：
  名称：

  Ambrogi; Cozzi; Sanjust, European Journal of Medicinal Chemistry, 1980, vol. 15, # 2, p. 157 - 163

  摘要：

  DOI：
• 作为产物：
  描述：

  5-甲基吡嗪-2-羧酸 、 二乙胺 在 氯甲酸乙酯 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 5-methyl-pyrazine-2-carboxylic acid diethylamide
  参考文献：
  名称：

  Ambrogi; Cozzi; Sanjust, European Journal of Medicinal Chemistry, 1980, vol. 15, # 2, p. 157 - 163

  摘要：

  DOI：

文献信息

• COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES
  申请人：Wang Tao

  公开号：US20080119480A1

  公开（公告）日：2008-05-22

  This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

  该发明提供了具有药物和生物影响性质的化合物，它们的制药组合物和使用方法。特别地，该发明涉及氮杂吲哌酮乙酰基哌嗪衍生物。这些化合物具有独特的抗病毒活性，无论是单独使用还是与其他抗病毒药物、抗感染药物、免疫调节剂或HIV进入抑制剂联合使用。更具体地，本发明涉及治疗HIV和艾滋病。
• PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES WITH PROTEASE INHIBITORS
  申请人：Wang Tao

  公开号：US20100093752A1

  公开（公告）日：2010-04-15

  This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

  本发明提供了具有药物和生物影响性质的化合物，它们的药物组合物和使用方法。特别是，本发明涉及氮杂吲哚氧乙酰哌嗪衍生物。这些化合物具有独特的抗病毒活性，无论是单独使用还是与其他抗病毒药物、抗感染药物、免疫调节剂或HIV进入抑制剂结合使用。更具体地，本发明涉及治疗HIV和艾滋病。
• PRODRUGS OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES
  申请人：Bristol-Myers Squibb Company

  公开号：US20150329543A1

  公开（公告）日：2015-11-19

  This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

  本发明提供具有药物和生物影响特性的化合物，其制药组合物和使用方法。特别地，本发明涉及氮杂吲哚氧乙酰基哌嗪衍生物。这些化合物具有独特的抗病毒活性，无论是单独使用还是与其他抗病毒药物、抗感染剂、免疫调节剂或HIV进入抑制剂联合使用。更具体地，本发明涉及治疗HIV和艾滋病。
• SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES
  申请人：Bristol-Myers Squibb Company

  公开号：US20150259342A1

  公开（公告）日：2015-09-17

  This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives having the Formula I: wherein Q is These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

  本发明提供了具有药物和生物影响性质的化合物，它们的制药组合物和使用方法。特别地，本发明涉及具有式I的氮杂吲哌酮乙酰基哌嗪衍生物，其中Q为。这些化合物具有独特的抗病毒活性，无论是单独使用还是与其他抗病毒药物、抗感染药物、免疫调节剂或HIV进入抑制剂联合使用。更具体地，本发明涉及治疗HIV和艾滋病。
• Thermodynamic N-Donor trans Influence in Labile Pseudo-Octahedral Zinc Complexes: A Delusion?
  作者：Lilit Aboshyan-Sorgho、Timothée Lathion、Laure Guénée、Céline Besnard、Claude Piguet

  DOI：10.1021/ic5022559

  日期：2014.12.15

  While the forces responsible for the chelate effect are well-established in coordination chemistry, the origin and implementation of the related thermodynamic trans influence remains debatable. This work illustrates a simple approach for quantifying this effect in labile pseudo-octahedral [Zn(Lk)(3)](2+) complexes lacking stereochemical preferences (Lk = L1L4 are unsymmetrical didentate a,a'-diimine ligands). In line with statistics, the triply degenerated meridional isomers mer-[Zn(Lk)(3)](2+) are stabilized by 0.8 = Delta G(exch)(mer)<= = 4.2 kJ/mol over their nondegenerated facial analogues fac-[Zn(Lk)(3)](2+) and therefore display no apparent trans influence at room temperature. However, the dissection of the free energy terms into opposite enthalpic (favoring the facial isomers) and entropic (favoring the meridional isomers) contributions reveals a trans influence assigned to solvation processes occurring in polar solvents. Altogether, the thermodynamic trans influence operating in [Zn(alpha,alpha'-diimine)(3)](2+) complexes is 12 orders of magnitude smaller than the chelate effect. A weak templating effect provided by a noncovalent lanthanide tripod is thus large enough to produce the wanted facial isomer at room temperature.